...
首页> 外文期刊>Bone >Usefulness of bone resorption markers in hemodialysis patients.
【24h】

Usefulness of bone resorption markers in hemodialysis patients.

机译:骨吸收标记物在血液透析患者中​​的有用性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although bone biopsy is a golden standard in the diagnosis of renal osteodystrophy, it is invasive and repetitive evaluation of bone status by this method is practically impossible. Non-invasive evaluation by bone metabolic markers such as serum cross-linked N-telopeptide of type I collagen (NTX) might give us additional information which cannot be obtained only by measurements of parathyroid hormone (PTH). These days, bone resorption marker, serum tartrate-resistant acid phosphatase (TRAP5b) was reported to be correlated with histomorphometric parameters of bone resorption in a bone biopsy study enrolling hemodialysis (HD) patients. In the current study, we studied the correlation of sera NTX and TRAP5b with bone mineral density (BMD) of second metacarpal bone in 103 HD patients and serial changes of these markers just after parathyroidectomy (PTX). Sera NTX and TRAP5b showed a significant positive relationship (R=0.79 P<0.0001). Simple regression analyses showed that both markers were significantly associated with BMD Z-score, whereas 1-84 PTH showed no significant association at all. This result might be attributed to diverse difference among HD patients in skeletal sensitivity to endogenous PTH. In fact, the ratios of TRAP5b/PTH and NTX/PTH denoting PTH sensitivity were significantly higher in postmenopausal female than male patients. Female gender, hemodialysis vintage, and log(PTH) were found to be significant positive determinants of serum log(TRAP5b) by multiple linear regression analysis. Receiver operating curve analysis for young adult mean 70% revealed that sensitivity was more than 95% when the cut-off value was set at 56.5 nmol BCE/L and 340 mU/L, but the specificity was only 29.5% and 34.4% for NTX and TRAP5b, respectively. Multiple regression analysis revealed that both markers were independent determinants of Z-score in two models including respective marker. Serial changes of both markers after PTX in 2 HD patients were comparable with gradual decrease of these markers. However, the reduction was sooner and larger in serum NTX. This sooner reduction might be attributed to the difference in characteristics of these markers regarding the effect of single HD session. Whereas serum NTX decreased, TRAP5b increased significantly after single session. Taken together, both markers give us additional information that cannot be obtained just by using PTH, provided that we know the characteristics of these markers.
机译:尽管骨活检是诊断肾性骨营养不良症的黄金标准,但它是侵入性的,通过这种方法重复评估骨状态实际上是不可能的。通过骨代谢标记物(如I型胶原蛋白的血清交联N端肽)的非侵入性评估可能会为我们提供其他信息,这些信息只能通过测量甲状旁腺激素(PTH)才能获得。如今,在进行血液透析(HD)患者的骨活检研究中,据报道骨吸收标志物,抗酒石酸血清酸性磷酸酶(TRAP5b)与骨吸收的组织形态学参数相关。在本研究中,我们研究了103例HD患者的血清NTX和TRAP5b与第二掌骨的骨矿物质密度(BMD)的相关性以及甲状旁腺切除术(PTX)后这些标志物的系列变化。血清NTX和TRAP5b呈显着正相关(R = 0.79 P <0.0001)。简单的回归分析表明,两种标记物均与BMD Z评分显着相关,而1-84 PTH则完全没有显着相关性。该结果可能归因于HD患者对内源性PTH的骨骼敏感性存在差异。实际上,表示绝经后女性的TRAP5b / PTH和NTX / PTH的比率显着高于男性患者。通过多元线性回归分析,发现女性,血液透析时间和log(PTH)是血清log(TRAP5b)的重要阳性决定因素。接收者工作曲线的年轻成年人平均值为70%,表明当临界值设置为56.5 nmol BCE / L和340 mU / L时,灵敏度超过95%,但NTX的特异性仅为29.5%和34.4%和TRAP5b。多元回归分析显示,在包括各自标志物的两个模型中,两个标志物都是Z评分的独立决定因素。 2名HD患者PTX后两种标志物的系列变化与这些标志物的逐渐减少相当。但是,血清NTX的降低更快且更大。这种较早的减少可能归因于这些标记在单个HD会话效果方面的特性差异。单次治疗后血清NTX降低,TRAP5b显着升高。综上所述,只要我们知道这些标记的特征,这两种标记都会为我们提供仅使用PTH无法获得的其他信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号